Baxter International (BAX) Projected to Post Earnings on Thursday

Baxter International (NYSE:BAX - Get Free Report) is projected to release its earnings data before the market opens on Thursday, February 13th. Analysts expect Baxter International to post earnings of $0.52 per share and revenue of $2.67 billion for the quarter. Persons interested in registering for the company's earnings conference call can do so using this link.

Baxter International Stock Up 0.7 %

NYSE BAX traded up $0.21 during mid-day trading on Friday, reaching $30.83. 3,855,412 shares of the company's stock traded hands, compared to its average volume of 4,512,161. Baxter International has a 1-year low of $28.33 and a 1-year high of $44.01. The company has a fifty day simple moving average of $30.57 and a 200-day simple moving average of $34.29. The company has a current ratio of 1.43, a quick ratio of 1.09 and a debt-to-equity ratio of 1.31. The company has a market cap of $15.74 billion, a price-to-earnings ratio of 154.16, a P/E/G ratio of 9.83 and a beta of 0.61.

Baxter International Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 1st. Shareholders of record on Friday, February 28th will be issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 2.21%. The ex-dividend date of this dividend is Friday, February 28th. Baxter International's dividend payout ratio is presently 340.02%.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the company. StockNews.com cut Baxter International from a "buy" rating to a "hold" rating in a report on Monday, November 11th. Stifel Nicolaus decreased their target price on Baxter International from $46.00 to $38.00 and set a "buy" rating on the stock in a report on Monday, November 11th. Finally, Citigroup lowered their price target on Baxter International from $37.00 to $35.00 and set a "neutral" rating on the stock in a report on Wednesday, December 11th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the company. According to MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $39.44.

Baxter International Company Profile

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.